Credit Agricole’s BELLUS Health Inc. BLU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4
| Closed | -$59 | – | 989 |
|
|
2023
Q2 | $59 | Hold |
4
| – | – | ﹤0.01% | 686 |
|
|
2023
Q1 | $29 | Hold |
4
| – | – | ﹤0.01% | 656 |
|
|
2022
Q4 | $33 | Hold |
4
| – | – | ﹤0.01% | 706 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 731 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 744 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 775 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 742 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 752 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 767 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 724 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 643 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 559 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 533 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 662 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 691 |
|
|
2019
Q3 | $0 | Buy |
+4
| New | +$28 | ﹤0.01% | 685 |
|
Other funds holding BLU
Credit Agricole's BLU Position: Q3 2023 in Review
Credit Agricole sold out of BELLUS Health Inc. (BLU) in Q3 2023, closing a stake of 4 shares — an estimated $59 sold.
Credit Agricole first reported a position in BLU in Q3 2019 and held it in 16 quarters. The position peaked at $59 in Q2 2023. 1 fund tracked by Wall St. Rank holds BLU as of Q3 2023.
- Credit Agricole reported no remaining BELLUS Health Inc. position as of Q3 2023 after selling out during the quarter.
- Credit Agricole sold 4 BELLUS Health Inc. shares in Q3 2023, an estimated $59.
- Credit Agricole first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 16 quarters.
- Credit Agricole's BELLUS Health Inc. position peaked at $59 in Q2 2023.
- 1 fund tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2023.
Based on Credit Agricole's 13F filing for Q3 2023, filed 14 Nov 2023.